Mar 1, 2012 | Posted by: roboblogger
Federal regulators have pushed back the deadline for deciding whether to approve a highly touted experimental anticlotting drug developed jointly by Pfizer Inc.
I believe there is a need for the US Food and Drug Administration to really look into this experimental anticlotting drug developed jointly by Pfizer Inc to avoid any kind of complication. The postponed is a good move. You may visit http://www.hiprecalllaw.com/ for more info.
Tell me when this thread is updated:
|Pfizer spent $2.3M lobbying government in 2Q (Sep '10)||2 hr||Vaccine Side effects||25|
|Appeals court backs scientist in Pfizer retalia...||11 hr||farhanjaffry||2|
|Lawsuits filed over Lipitor side effects (Jun '06)||11 hr||steve chase||740|
|Milwaukee Schools / Union wants Viagra back in ... (Aug '10)||18 hr||Tyshawn||7|
|tanezumab arthritis study (Jul '10)||Tue||Hope For Us||95|
|Pfizer breast cancer drug gets breakthrough label||Tue||Colleen||1|
|NYC Man Sued Over 25-Foot Viagra Rocket (Oct '08)||May 19||Grant||23|